最新消息

Qt Promotion: Unlocking Growth in ASEAN's Booming Healthcare Market - September/October 2024

Qt Promotion: Unlocking Growth in ASEAN's Booming Healthcare Market - September/October 2024

  • 2024-10-10 10:03:44

The ASEAN region is rapidly emerging as a vital player in the global healthcare industry, offering immense opportunities for growth and expansion. For medical device companies looking to enter this dynamic market, partnering with Qualtech Consulting Corporation provides the expertise, support, and local knowledge necessary to navigate the complexities of regulatory approval and achieve success. Don't miss the chance to expand your business in one of the world's most exciting healthcare markets—let Qualtech guide you every step of the way.

了解更多
Revolutionizing Indonesia's Healthcare Landscape – An Insight into Government Mega Projects and the Medical Device Market - September/October 2024

Revolutionizing Indonesia's Healthcare Landscape – An Insight into Government Mega Projects and the Medical Device Market - September/October 2024

  • 2024-10-10 09:41:55

Indonesia is transforming its healthcare system through three major government projects: SIHREN, SOPHI, and INPULS. These initiatives aim to improve healthcare services, enhance access to specialized care, and strengthen the public laboratory system, addressing major diseases like cancer and heart disease. The projects also present significant opportunities for medical device manufacturers and regulatory consultants to align their offerings with Indonesia’s evolving healthcare needs.

了解更多
Singapore: Consultation on Guidance of Change Management Program (CMP) for SaMD – September/October 2024

Singapore: Consultation on Guidance of Change Management Program (CMP) for SaMD – September/October 2024

  • 2024-10-10 08:46:48

HSA's Medical Devices Cluster has released a draft of Guidance on Change Management Program (CMP) for stakeholders with consultation period from 26 August 2024 to 21 October 2024. The new optional regulatory pathway aims to accommodate the rapid iterative nature of SaMD changes. This guidance explains on the CMP definition, scope, eligibility, requirements, and process. The guidance also introduces the concept of 'Pre-specified' changes. Feedback on the guidance draft can be sent to HSA through email by using prescribed feedback form.

了解更多
Thailand: Thai FDA Implements Urgent Registration for Mpox Test Kits Amid Growing Public Health Concerns – September/October 2024

Thailand: Thai FDA Implements Urgent Registration for Mpox Test Kits Amid Growing Public Health Concerns – September/October 2024

  • 2024-10-10 08:23:53

The Thai Food and Drug Administration (FDA) has initiated a registration process for Mpox diagnostic test kits in response to rising concerns over the spread of the viral infection. This move aims to enhance early detection and management of Mpox cases, ensuring public health safety. The Thai FDA has streamlined the registration process for manufacturers and importers, focusing on quality and accuracy of the diagnostic kits. This initiative is a key step in Thailand's efforts to curb the spread of the virus and strengthen its response to emerging health threats.

了解更多
Australia: TGA released guidance to clarify the regulatory obligations of sponsors and manufacturers with exempt medical devices - August/September 2024

Australia: TGA released guidance to clarify the regulatory obligations of sponsors and manufacturers with exempt medical devices - August/September 2024

  • 2024-09-17 06:17:58

Australia's TGA has issued new guidelines for exempt medical devices, clarifying that while not requiring ARTG registration, these products still face strict oversight. Manufacturers must adhere to reporting, recall, advertising, and quality standards to ensure patient safety. Non-compliance can result in penalties.

了解更多